Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Sep 2023)

Long‐Term Impact of Additional Ablation After Pulmonary Vein Isolation: Results From EARNEST‐PVI Trial

  • Masaharu Masuda,
  • Koichi Inoue,
  • Nobuaki Tanaka,
  • Tetsuya Watanabe,
  • Nobuhiko Makino,
  • Yasuyuki Egami,
  • Takafumi Oka,
  • Hitoshi Minamiguchi,
  • Miwa Miyoshi,
  • Masato Okada,
  • Takashi Kanda,
  • Toshiaki Mano,
  • Yasuhiro Matsuda,
  • Hiroyuki Uematsu,
  • Takashige Sakio,
  • Masato Kawasaki,
  • Akihiro Sunaga,
  • Yohei Sotomi,
  • Tomoharu Dohi,
  • Daisaku Nakatani,
  • Shungo Hikoso,
  • Yasushi Sakata

DOI
https://doi.org/10.1161/JAHA.123.029651
Journal volume & issue
Vol. 12, no. 17

Abstract

Read online

Background An optimal strategy for left atrial ablation in addition to pulmonary vein isolation (PVI) in patients with persistent atrial fibrillation (AF) has not been determined. Methods and Results We conducted an extended follow‐up of the multicenter randomized controlled EARNEST‐PVI (Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation) trial, which compared 12‐month rhythm outcomes in patients with persistent AF between patients randomized to a PVI‐alone strategy (n=248) or PVI‐plus strategy (n=248; PVI followed by left atrial additional ablation, including linear ablation or ablation targeting areas with complex fractionated electrograms). The present study extended the follow‐up period to 3 years after enrollment. Outcomes were compared not only between randomly allocated groups but also between on‐treatment groups categorized by actually created ablation lesions. Recurrence rate of AF or atrial tachycardia (AT) was lower in the randomly allocated to PVI‐plus group than the PVI‐alone group (29.0% versus 37.5%, P=0.036). On‐treatment analysis revealed that patients with PVI+linear ablation (n=205) demonstrated a lower AF/AT recurrence rate than those with PVI only (26.3% versus 37.8%, P=0.007). In contrast, patients with PVI+complex fractionated electrograms ablation (n=37) had an AF/AT recurrence rate comparable to that of patients with PVI only (40.5% versus 37.8%, P=0.76). At second ablation in 126 patients with AF/AT recurrence, ATs excluding common atrial flutter were more frequent in patients with PVI+linear ablation than in those with PVI only (32.6% versus 5.7%, P<0.0001). Conclusions Left atrial ablation in addition to PVI was efficacious during 3‐year follow‐up. Linear ablation was superior to other ablation strategies but may increase iatrogenic ATs. Registration URL: http://www.umin.ac.jp/ctr/index‐j.htm; Unique identifier: UMIN000019449.

Keywords